Alvotech (ALVO) shares rallied 8.6% in the last trading session to close at 8.7.Thismovecanbeattributabletonotablevolumewithahighernumberofsharesbeingtradedthaninatypicalsession.Thiscomparestothestock′s3.78.7. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 3.7% loss over the past four weeks.Alvotech extended its rally for a second day, fueled by optimism after the EMA’s CHMP backed its regulatory filings for biosimilar versions of Amgen’s Prolia/Xgeva and J&J’s Simponi.This company is expected to post quarterly earnings of 8.7.Thismovecanbeattributabletonotablevolumewithahighernumberofsharesbeingtradedthaninatypicalsession.Thiscomparestothestock′s3.70.08 per ...
Alvotech(US:ALVO) ZACKS·2025-09-24 08:46